---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-000717"
form_type: "8-K"
ticker: "HSDT"
cik: "0001610853"
company_name: "Solana Co"
filed_at: "2025-02-07T23:59:59+00:00"
generated_at: "2026-05-27T00:55:24.708349+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Helius Medical faces Nasdaq delisting; to appeal, sets 2025 annual meeting for April 21

## Summary
- Received Nasdaq delisting notice on Feb 7, 2025 for continued bid price below $1; intends to appeal, hearing stays delisting.
- On Jan 21, 2025, entered warrant inducement to exercise existing warrants at $0.751/share for 4.97M shares, issuing new warrants for up to 6.21M shares pending stockholder approval.
- 2025 Annual Meeting set for April 21, 2025; record date March 12, 2025; stockholder proposal and director nomination deadline is Feb 17, 2025.
- No assurance of regaining compliance; common stock remains listed on Nasdaq pending hearing outcome.

## SEC filing metadata
- accession: 0001558370-25-000717
- form_type: 8-K
- ticker: HSDT
- cik: 0001610853
- company_name: Solana Co
- filed_at: 2025-02-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01, 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610853/000155837025000717/0001558370-25-000717-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610853/000155837025000717/hsdt-20250207x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-000717
- JSON: https://secwatch.observer/filing/0001558370-25-000717.json
- Plain text: https://secwatch.observer/filing/0001558370-25-000717.txt

## Source-grounded claims
- claim_id: 89427dc594c836aa3d198af9c16482babc0c7799
  claim: Solana Co received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: February 7, 2025, the Company received a letter from the Staff indicating the Company’s continued non-compliance with the Minimum Bid Price Requirement. The letter further informed the Company that the Company’s common s
  evidence_url: https://www.sec.gov/Archives/edgar/data/1610853/000155837025000717/0001558370-25-000717-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.